B. Tao

Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.

Y. Handelsman, Stacey L. Abby, Michael R. Jones, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor

J. Stark, H. Zahir, Sonomi Maruyama, 2022, Clinical and translational science.

The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.

J. Rosenstock, H. Chou, B. Tao, 2013, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS‐3801b, a Motilin Receptor Agonist, in Healthy Subjects

G. Senaldi, G. Atiee, V. Warren, 2017, Journal of clinical pharmacology.

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.

Ling He, James Lee, P. Wickremasingha, 2014, Diabetes research and clinical practice.

A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension

R. Heyrman, K. Miyazaki, A. Bhorat, 2010, Hypertension.

The effects of colesevelam HCl on the single‐dose pharmacokinetics of glimepiride, extended‐release glipizide, and olmesartan medoxomil

Ling He, James Lee, P. Wickremasingha, 2014, Journal of clinical pharmacology.

Efficacy and Safety of Colesevelam in Combination with Pioglitazone in Patients with Type 2 Diabetes Mellitus

J. Rosenstock, K. Truitt, H. Chou, 2014, Hormone and Metabolic Research.

A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas

R. Doebele, G. Schwartz, M. Gounder, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

S. Hohnloser, E. Prystowsky, S. Saksena, 1999, The New England journal of medicine.